339 related articles for article (PubMed ID: 24390753)
1. Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis.
Tabibian JH; O'Hara SP; Splinter PL; Trussoni CE; LaRusso NF
Hepatology; 2014 Jun; 59(6):2263-75. PubMed ID: 24390753
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.
Loarca L; De Assuncao TM; Jalan-Sakrikar N; Bronk S; Krishnan A; Huang B; Morton L; Trussoni C; Bonilla LM; Krueger E; O'Hara S; Splinter P; Shi G; Pisarello MJL; Gores GJ; Huebert RC; LaRusso NF
Lab Invest; 2017 Nov; 97(11):1385-1396. PubMed ID: 28892096
[TBL] [Abstract][Full Text] [Related]
3. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the
Alsuraih M; O'Hara SP; Woodrum JE; Pirius NE; LaRusso NF
JHEP Rep; 2021 Jun; 3(3):100250. PubMed ID: 33870156
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis.
Cazzagon N; Sarcognato S; Floreani A; Corrà G; De Martin S; Guzzardo V; Russo FP; Guido M
JHEP Rep; 2021 Jun; 3(3):100286. PubMed ID: 34041468
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis.
Tabibian JH; Trussoni CE; O'Hara SP; Splinter PL; Heimbach JK; LaRusso NF
Lab Invest; 2014 Oct; 94(10):1126-33. PubMed ID: 25046437
[TBL] [Abstract][Full Text] [Related]
6. Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor.
Al Suraih MS; Trussoni CE; Splinter PL; LaRusso NF; O'Hara SP
Liver Int; 2020 Oct; 40(10):2455-2468. PubMed ID: 32558183
[TBL] [Abstract][Full Text] [Related]
7. ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte Senescence-associated Protein Cyclin-dependent Kinase Inhibitor 2A.
O'Hara SP; Splinter PL; Trussoni CE; Pisarello MJ; Loarca L; Splinter NS; Schutte BF; LaRusso NF
J Biol Chem; 2017 Mar; 292(12):4833-4846. PubMed ID: 28184004
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
[TBL] [Abstract][Full Text] [Related]
9. Human placenta mesenchymal stem cell-derived exosomes delay H
Chen W; Zhu J; Lin F; Xu Y; Feng B; Feng X; Sheng X; Shi X; Pan Q; Yang J; Yu J; Li L; Cao H
Stem Cell Res Ther; 2021 Mar; 12(1):201. PubMed ID: 33752720
[TBL] [Abstract][Full Text] [Related]
10. Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation.
Jalan-Sakrikar N; De Assuncao TM; Navarro-Corcuera A; Hamdan FH; Loarca L; Kirkeby LA; Resch ZT; O'Hara SP; Juran BD; Lazaridis KN; Rosen CB; Heimbach JK; Taner T; Shah VH; LaRusso NF; Huebert RC
Hepatol Commun; 2022 Feb; 6(2):345-360. PubMed ID: 34519176
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
12. Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.
Tabibian JH; O'Hara SP; Trussoni CE; Tietz PS; Splinter PL; Mounajjed T; Hagey LR; LaRusso NF
Hepatology; 2016 Jan; 63(1):185-96. PubMed ID: 26044703
[TBL] [Abstract][Full Text] [Related]
13. Cellular senescence in the cholangiopathies.
Bogert PS; O'Hara SP; LaRusso NF
Curr Opin Gastroenterol; 2022 Mar; 38(2):121-127. PubMed ID: 35098933
[TBL] [Abstract][Full Text] [Related]
14. The Epigenetic Reader, Bromodomain Containing 2, Mediates Cholangiocyte Senescence via Interaction With ETS Proto-Oncogene 1.
Kang JH; Splinter PL; Trussoni CE; Pirius NE; Gores GJ; LaRusso NF; O'Hara SP
Gastroenterology; 2023 Jul; 165(1):228-243.e2. PubMed ID: 37059338
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor ETS1 promotes apoptosis resistance of senescent cholangiocytes by epigenetically up-regulating the apoptosis suppressor BCL2L1.
O'Hara SP; Splinter PL; Trussoni CE; Guicciardi ME; Splinter NP; Al Suraih MS; Nasser-Ghodsi N; Stollenwerk D; Gores GJ; LaRusso NF
J Biol Chem; 2019 Dec; 294(49):18698-18713. PubMed ID: 31659122
[TBL] [Abstract][Full Text] [Related]
16. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
Trussoni CE; O'Hara SP; LaRusso NF
Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2
Zhou T; Kyritsi K; Wu N; Francis H; Yang Z; Chen L; O'Brien A; Kennedy L; Ceci L; Meadows V; Kusumanchi P; Wu C; Baiocchi L; Skill NJ; Saxena R; Sybenga A; Xie L; Liangpunsakul S; Meng F; Alpini G; Glaser S
EBioMedicine; 2019 Oct; 48():130-142. PubMed ID: 31522982
[TBL] [Abstract][Full Text] [Related]
18. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2
Meadows V; Kennedy L; Hargrove L; Demieville J; Meng F; Virani S; Reinhart E; Kyritsi K; Invernizzi P; Yang Z; Wu N; Liangpunsakul S; Alpini G; Francis H
Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165557. PubMed ID: 31521820
[TBL] [Abstract][Full Text] [Related]
20. Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2
Moncsek A; Al-Suraih MS; Trussoni CE; O'Hara SP; Splinter PL; Zuber C; Patsenker E; Valli PV; Fingas CD; Weber A; Zhu Y; Tchkonia T; Kirkland JL; Gores GJ; Müllhaupt B; LaRusso NF; Mertens JC
Hepatology; 2018 Jan; 67(1):247-259. PubMed ID: 28802066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
